{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:54:38Z","timestamp":1762005278055,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.diagmicrobio.2020.115305","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T08:17:59Z","timestamp":1610093879000},"page":"115305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT)"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-0692","authenticated-orcid":false,"given":"Joyeeta","family":"Palit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-5835","authenticated-orcid":false,"given":"Joby","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3130-9724","authenticated-orcid":false,"given":"Oyewole Christopher","family":"Durojaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0001","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/jac\/dkw470","article-title":"Development of operationalized intravenous to oral antibiotic switch criteria","volume":"72","author":"Akhloufi","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0002","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamadermatol.2014.1085","article-title":"The impact of dermatology consultation on diagnostic accuracy and antibiotic use among patients with suspected cellulitis seen at outpatient internal medicine offices a randomized clinical trial","volume":"150","author":"Arakaki","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0003","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2165\/0003495-200868170-00005","article-title":"Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis","volume":"68","author":"Athanassa","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0004","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0000000000000434","article-title":"When to switch to an oral treatment and\/or to discharge a patient with skin and soft tissue infections","volume":"31","author":"Bassetti","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0005","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/jac\/dkw129","article-title":"What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors\u2019 accounts of what influences their clinical practice","volume":"71","author":"Broom","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0006","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s12879-017-2569-4","article-title":"Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore","volume":"17","author":"Chan","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0007","doi-asserted-by":"crossref","first-page":"dlz026","DOI":"10.1093\/jacamr\/dlz026","article-title":"Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK","volume":"1","author":"Chapman","year":"2019","journal-title":"JAC-Antimicrobial Resist"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QCO.0000000000000440","article-title":"The optimal duration of treatment for skin and soft tissue infections and acute bacterial skin and skin structure infections","volume":"31","author":"Corcione","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0009","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jinf.2020.07.030","article-title":"Route and duration of antibiotic therapy in acute cellulitis: a systematic review and meta-analysis of the effectiveness and harms of antibiotic treatment","volume":"81","author":"Cross","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4103\/0976-500X.130042","article-title":"Switch over from intravenous to oral therapy: a concise overview","volume":"5","author":"Cyriac","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0011","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/jac\/dks193","article-title":"Antibiotic stewardship and early discharge from hospital: Impact of a structured approach to antimicrobial management","volume":"67","author":"Dryden","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0012","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2017.03.016","article-title":"Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service","volume":"51","author":"Durojaiye","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.diagmicrobio.2018.07.013","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acure hospital trusts and health boards","volume":"93","author":"Durojaiye","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"year":"2005","series-title":"Guidelines on the management of cellulitis in adults","author":"Fulton","key":"10.1016\/j.diagmicrobio.2020.115305_bib0014"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0015","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0016","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0017","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0018","first-page":"190","article-title":"Clinicians\u2019 knowledge, beliefs and acceptance of intravenous-to-oral antibiotic switching, hospital Pulau Pinang","volume":"67","author":"Lee","year":"2012","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0019","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10096-009-0855-9","article-title":"Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting","volume":"29","author":"Lillie","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.diagmicrobio.2020.115305_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000048564","article-title":"The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom","volume":"47","author":"Nathwani","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0022","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijantimicag.2016.04.023","article-title":"Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe","volume":"48","author":"Nathwani","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0023","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","article-title":"Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial","volume":"333","author":"Oosterheert","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0024","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dki092","article-title":"Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone","volume":"55","author":"Seaton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijantimicag.2011.05.008","article-title":"Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections","volume":"38","author":"Seaton","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0026","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000441-200508000-00002","article-title":"Impact of mandatory inpatient infectious disease consultation on outpatient parenteral antibiotic therapy","volume":"330","author":"Sharma","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0027","doi-asserted-by":"crossref","first-page":"22","DOI":"10.52964\/AMJA.0451","article-title":"Delivering outpatient antibiotic therapy (OPAT) in an Acute Medical Unit","volume":"10","author":"Yan","year":"2011","journal-title":"Acute Med"},{"key":"10.1016\/j.diagmicrobio.2020.115305_bib0028","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10096-016-2631-y","article-title":"OPAT for cellulitis: its benefits and the factors that predispose to longer treatment","volume":"35","author":"Zhang","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320306829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320306829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:54:46Z","timestamp":1760003686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320306829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0732889320306829"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115305","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and operational factors associated with treatment duration for cellulitis in outpatient parenteral antimicrobial therapy (OPAT)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115305"}}